Arkin Moshe
CIK 0001321178 Name as filed on the most recent filing
Filed as Arkin Moshe (87)
1,086 transaction lines · from 87 filings · filed 2008-02-21 to 2021-05-04 The span is the filing dates this catalog holds, not the entity's full filing history. Absence here is not evidence of absence at the SEC.
A line appears here when the filing that carries it names this CIK as a reporting owner, not only when the parser picked this CIK as the line's primary owner. That is why a joint filing appears on both owners' pages rather than vanishing from the second one. The catalog never merges two CIKs into one person and never splits one CIK into two: identity here is the SEC's own identifier and nothing else.
Issuers this insider has filed against
Ordered by last-seen filing date, newest first. Roles are as filed on the Form 4 and are not normalised.
This container could not be filled from the store. It is showing nothing because a read failed, not because no insider filed: those are different facts and this catalog will not let one stand in for the other. The last ingest the store recorded was 2026-08-21 05:23 UTC.
- ISSUER Werewolf Therapeutics, Inc. 1 filings
- ISSUER Keros Therapeutics, Inc. 1 filings
- ISSUER Perrigo Co 73 filings
- ISSUER NeurogesX Inc 9 filings
- ISSUER Orexigen Therapeutics, Inc. 1 filings
- ISSUER Ophthalmic Imaging Systems 2 filings
No issuer is recorded
The catalog holds no filing linking this CIK to an issuer.
Transactions
Every stored Form 4 line naming this reporting owner, newest transaction date first. Each row links to the filing it came from.
1,028 transactions · Newest transaction date first, id breaking the tie.
This container could not be filled from the store. It is showing nothing because a read failed, not because no insider filed: those are different facts and this catalog will not let one stand in for the other. The last ingest the store recorded was 2026-08-21 05:23 UTC.
| Direction | Date | Issuer | Code | Shares | Price | Value USD | Filing |
|---|---|---|---|---|---|---|---|
| 2021-05-04 |
Werewolf Therapeutics, Inc. HOWL |
P, Open-market purchase | 400,000 acquired | 16.00 | 6,400,000.00 | Form 4, filing 0000899243-21-018121 | |
| 2020-04-13 |
Keros Therapeutics, Inc. KROS |
P, Open-market purchase | 120,000 acquired | 16.00 | 1,920,000.00 | Form 4, filing 0001178913-20-001105 | |
| 2011-08-31 |
Perrigo Co PRGO |
S, Open-market sale | 52,591 disposed | 96.20 | 5,059,469.82 | Form 4, filing 0001181431-11-047817 | |
| 2011-08-31 |
Perrigo Co PRGO |
S, Open-market sale | 13,715 disposed | 95.18 | 1,305,338.84 | Form 4, filing 0001181431-11-047817 | |
| 2011-08-31 |
Perrigo Co PRGO |
S, Open-market sale | 13,549 disposed | 94.55 | 1,281,053.89 | Form 4, filing 0001181431-11-047817 | |
| 2011-08-30 |
Perrigo Co PRGO |
S, Open-market sale | 170,145 disposed | 96.46 | 16,411,795.37 | Form 4, filing 0001181431-11-047700 | |
| 2011-08-10 |
NeurogesX Inc NGSX |
S, Open-market sale | 82,109 disposed | 2.00 | 164,571.07 | Form 4, filing 0001178913-11-002277 | |
| 2011-08-09 |
NeurogesX Inc NGSX |
S, Open-market sale | 81,359 disposed | 2.15 | 175,174.06 | Form 4, filing 0001178913-11-002277 | |
| 2011-06-27 |
NeurogesX Inc NGSX |
S, Open-market sale | 1,079 disposed | 2.10 | 2,270.65 | Form 4, filing 0001178913-11-001806 | |
| 2011-06-24 |
NeurogesX Inc NGSX |
S, Open-market sale | 7,499 disposed | 2.10 | 15,753.15 | Form 4, filing 0001178913-11-001806 | |
| 2011-06-23 |
NeurogesX Inc NGSX |
S, Open-market sale | 50,000 disposed | 2.09 | 104,535.00 | Form 4, filing 0001178913-11-001800 | |
| 2011-06-16 |
NeurogesX Inc NGSX |
S, Open-market sale | 300,000 disposed | 3.20 | 961,380.00 | Form 4, filing 0001178913-11-001772 | |
| 2011-05-20 |
Perrigo Co PRGO |
S, Open-market sale | 400 disposed | 87.00 | 34,800.00 | Form 4, filing 0001181431-11-032245 | |
| 2011-05-19 |
Perrigo Co PRGO |
S, Open-market sale | 37,557 disposed | 87.04 | 3,269,002.59 | Form 4, filing 0001181431-11-031372 | |
| 2011-05-18 |
Perrigo Co PRGO |
S, Open-market sale | 142,805 disposed | 86.31 | 12,325,885.12 | Form 4, filing 0001181431-11-031372 | |
| 2011-05-13 |
Perrigo Co PRGO |
S, Open-market sale | 7,195 disposed | 87.78 | 631,590.77 | Form 4, filing 0001181431-11-029783 | |
| 2011-05-12 |
Perrigo Co PRGO |
S, Open-market sale | 100,000 disposed | 87.43 | 8,742,630.00 | Form 4, filing 0001181431-11-029783 | |
| 2011-05-11 |
Perrigo Co PRGO |
S, Open-market sale | 50,175 disposed | 87.24 | 4,377,312.16 | Form 4, filing 0001181431-11-029074 | |
| 2011-05-10 |
Perrigo Co PRGO |
S, Open-market sale | 78,553 disposed | 87.52 | 6,874,612.93 | Form 4, filing 0001181431-11-029074 | |
| 2011-05-09 |
Perrigo Co PRGO |
S, Open-market sale | 141,127 disposed | 87.63 | 12,366,563.85 | Form 4, filing 0001181431-11-028492 | |
| 2011-05-06 |
Perrigo Co PRGO |
S, Open-market sale | 59,795 disposed | 87.06 | 5,205,902.19 | Form 4, filing 0001181431-11-028492 | |
| 2011-05-06 |
Perrigo Co PRGO |
S, Open-market sale | 5,300 disposed | 87.79 | 465,304.49 | Form 4, filing 0001181431-11-028492 | |
| 2011-05-05 |
Perrigo Co PRGO |
S, Open-market sale | 165,050 disposed | 86.03 | 14,199,581.60 | Form 4, filing 0001181431-11-028056 | |
| 2011-03-25 |
NeurogesX Inc NGSX |
S, Open-market sale | 120,000 disposed | 4.02 | 482,940.00 | Form 4, filing 0001178913-11-000893 | |
| 2011-03-24 |
NeurogesX Inc NGSX |
S, Open-market sale | 32,600 disposed | 4.07 | 132,610.28 | Form 4, filing 0001178913-11-000893 | |
| 2011-03-23 |
NeurogesX Inc NGSX |
S, Open-market sale | 12,100 disposed | 4.01 | 48,536.73 | Form 4, filing 0001178913-11-000875 | |
| 2011-03-03 |
Perrigo Co PRGO |
S, Open-market sale | 16,869 disposed | 77.20 | 1,302,337.41 | Form 4, filing 0001181431-11-015611 | |
| 2011-03-03 |
Perrigo Co PRGO |
S, Open-market sale | 5,230 disposed | 77.55 | 405,600.10 | Form 4, filing 0001181431-11-015611 | |
| 2011-03-02 |
Perrigo Co PRGO |
S, Open-market sale | 55,237 disposed | 76.38 | 4,219,024.15 | Form 4, filing 0001181431-11-015611 | |
| 2011-03-02 |
Perrigo Co PRGO |
S, Open-market sale | 22,664 disposed | 76.96 | 1,744,108.12 | Form 4, filing 0001181431-11-015611 | |
| 2011-03-01 |
Perrigo Co PRGO |
S, Open-market sale | 45,779 disposed | 76.48 | 3,501,278.63 | Form 4, filing 0001181431-11-014418 | |
| 2011-03-01 |
Perrigo Co PRGO |
S, Open-market sale | 4,221 disposed | 77.06 | 325,267.31 | Form 4, filing 0001181431-11-014418 | |
| 2011-02-28 |
Perrigo Co PRGO |
S, Open-market sale | 50,000 disposed | 76.19 | 3,809,665.00 | Form 4, filing 0001181431-11-014418 | |
| 2011-02-28 |
Perrigo Co PRGO |
S, Open-market sale | 34,513 disposed | 76.16 | 2,628,441.05 | Form 4, filing 0001181431-11-014418 | |
| 2011-02-25 |
Perrigo Co PRGO |
S, Open-market sale | 24,970 disposed | 75.28 | 1,879,816.51 | Form 4, filing 0001181431-11-013837 | |
| 2011-02-25 |
Perrigo Co PRGO |
S, Open-market sale | 18,904 disposed | 75.81 | 1,433,117.91 | Form 4, filing 0001181431-11-013837 | |
| 2011-02-22 |
Perrigo Co PRGO |
S, Open-market sale | 43,626 disposed | 74.41 | 3,246,223.75 | Form 4, filing 0001181431-11-012654 | |
| 2011-02-22 |
Perrigo Co PRGO |
S, Open-market sale | 12,500 disposed | 75.46 | 943,247.50 | Form 4, filing 0001181431-11-012654 | |
| 2011-02-18 |
Perrigo Co PRGO |
S, Open-market sale | 200,000 disposed | 75.69 | 15,138,420.00 | Form 4, filing 0001181431-11-011673 | |
| 2011-02-17 |
Perrigo Co PRGO |
S, Open-market sale | 58,841 disposed | 76.22 | 4,484,849.25 | Form 4, filing 0001181431-11-011474 | |
| 2011-02-17 |
Perrigo Co PRGO |
S, Open-market sale | 26,510 disposed | 75.16 | 1,992,608.24 | Form 4, filing 0001181431-11-011474 | |
| 2011-02-17 |
Perrigo Co PRGO |
S, Open-market sale | 2,300 disposed | 76.75 | 176,533.74 | Form 4, filing 0001181431-11-011474 | |
| 2011-02-16 |
Perrigo Co PRGO |
S, Open-market sale | 182,924 disposed | 74.68 | 13,661,130.17 | Form 4, filing 0001181431-11-011474 | |
| 2011-02-16 |
Perrigo Co PRGO |
S, Open-market sale | 13,307 disposed | 75.78 | 1,008,383.17 | Form 4, filing 0001181431-11-011474 | |
| 2011-02-16 |
Perrigo Co PRGO |
S, Open-market sale | 3,769 disposed | 76.52 | 288,386.17 | Form 4, filing 0001181431-11-011474 | |
| 2010-09-09 |
NeurogesX Inc NGSX |
P, Open-market purchase | 30,000 acquired | 5.50 | 165,000.00 | Form 4, filing 0001178913-10-002416 | |
| 2010-07-15 |
Orexigen Therapeutics, Inc. OREX |
S, Open-market sale | 105,000 disposed | 5.64 | 591,685.50 | Form 4, filing 0001178913-10-002122 | |
| 2010-07-12 |
Orexigen Therapeutics, Inc. OREX |
S, Open-market sale | 135,000 disposed | 4.15 | 560,182.50 | Form 4, filing 0001178913-10-002122 | |
| 2010-07-12 |
Orexigen Therapeutics, Inc. OREX |
S, Open-market sale | 20,000 disposed | 4.15 | 82,990.00 | Form 4, filing 0001178913-10-002122 | |
| 2010-05-26 |
Ophthalmic Imaging Systems OISI |
P, Open-market purchase | 3,581,089 acquired | Not reported | Not priced | Form 4, filing 0001140361-10-024996 |
This column is intentionally blank
No transaction line is stored for this reporting owner, though the catalog holds filings naming them. That happens when the filings report only holdings or only positions the store does not carry, and when a parse failed; each filing page states its own parse status.
- P, Open-market purchase
- Open-market purchase
- S, Open-market sale
- Open-market sale
Every value is as reported on the Form 4. A price the filing did not report is marked Not reported and no value is computed from it. Codes outside the open market, drawn in grey behind a dashed rule, are compensation and administrative machinery rather than a decision to trade at the prevailing price.
What this insider's stored lines contain
Exact counts over every stored line for this entity. This is a statement of composition, not a filter: the only filter this page offers is the open-market one above, because that is the only one an index serves today.
- Open-market purchase 1
- Open-market sale 1,027
- Option exercise 0
- Grant or award 0
- Tax withholding 0
- Disposition to the issuer 0
- In-the-money option exercise 0
How to cite this page
ebomi catalog. Arkin Moshe, insider transactions. Retrieved 2026-08-21 from https://ebomi.com/insider/0001321178
Balogh, A. Insider trading. Scientific Data 10, 237 (2023) doi:10.1038/s41597-023-02147-6